Mechano-therapeutics Discovery Startup Forcyte Bio Secures New Funding From Y Combinator & Others, Bringing Total to >$5.7 Million, to Develop Drug Pipeline
yahoo.com
news
2022-06-01 19:16:00

LOS ANGELES, June 01, 2022--(BUSINESS WIRE)--Forcyte Biotechnologies, a tech-enabled drug discovery company targeting diseases of mechanobiology, has secured new funding from Milestone View, Pioneer Fund, Acequia Capital, Y Combinator, Jude Gomila (CEO, Golden), and others. Including public support, this funding brings Forcyte's total raised to $5.7M for their internal "mechano-therapeutic" pipeline, focusing first on fibrosis.

Forcyte's mission is to chart mechanobiology by using their unique platform to quantify - at extreme scale - the mechanical forces generated by various human cell types, and to leverage this high-dimensional data-map to develop better drugs, faster.
